[ |
|
How is Atrial Fibrillation Treated? Currently the primary goals of atrial fibrillation therapy are as follows:
Unfortunately, each of these therapies for atrial fibrillation involves certain potential risks and side effects. Like everything in medical care, you and your doctor will carefully balance the risks of the treatment, the risks of atrial fibrillation, and the benefits of therapy.
Medications Used To Treat Atrial Fibrillation Some patients will need medications only for a limited time if a correctable cause for atrial fibrillation is identified and treated. Most individuals, however, will need medication on a regular basis either to control the continuing arrhythmia or to prevent recurrence. Your doctor will choose a medical regimen tailored to your individual needs and your response to the drug. Since your response to any given medicine is difficult to predict, you will very likely need dose adjustments or a switch to another medication depending on your response. All medications have possible side effects and precautionary notes which you will need to discuss with your doctor or pharmacist. Once you have been started on a regimen, you should take your medications exactly as directed. Never change the dose or discontinue them without your doctor's supervision. There are three types of medications that your doctor will choose from, usually in combinations of at least one from each category. Medications to slow the heart rate - These medications will not prevent or stop the fibrillation, but will slow the heart rate to a more normal range. The widely used digoxin, usually the initially prescribed medicine, belongs in this category. It is actually one of the oldest medicines known, being derived from the foxglove plant. (Don't try to eat the leaves of that plant: In uncontrolled doses, foxglove can be poisonous!)
Medications to "thin" the blood - These medications are intended to reduce your risk of blood clot formation and stroke (anticoagulation therapy). If you are a diabetic, have high blood pressure, or have an enlarged heart, your risk of stroke with atrial fibrillation is particularly high. For those over 65 years of age, anticoagulation therapy using a medicine called warfarin has become the customary treatment for prevention of stroke. This therapy does not completely eliminate your risk, but will reduce it by over 50%. Patients taking this drug must be closely monitored with regular blood tests to continuously assess the amount of blood thinning. A level too low would keep you at risk for developing clots, and a level too high will put you at risk for bleeding. The blood pressure must also be kept under control. Taking extra precautions in the activities of daily living (shaving, playing contact sports, etc.) is another adjustment that you will need to make in your life, due to the increased risk of bleeding. The benefit of using warfarin to prevent blood clot formation needs to be balanced against the bleeding risks if you have high blood pressure, are elderly or unsteady with a history of falling, which can result in serious bleeding. Your doctor may choose to treat you with aspirin therapy instead, a milder form of blood thinner. It may not, however, be as effective as warfarin in the prevention of embolic strokes. You will need to consult your physician or pharmacist regarding the use of analgesics other than aspirin when you are on anticoagulation therapy. There is debate on the treatment of choice for younger patients with "lone" atrial fibrillation, but we often recommend one aspirin a day, just to be on the safe side.
You may be a candidate for the "electrical" therapy, or the DC cardioversion (direct current cardioversion) if you have persistent atrial fibrillation. This is the use of an electrical current through the chest wall while you are under short-acting anesthesia to "reset" the electrical pattern from atrial fibrillation to normal sinus rhythm. Initially, electrical cardioversion is successful in 70- 80% of patients. When the first attempt at DC cardioversion fails, it may be successful after the addition of antiarrhythmic medication. The success rate is decreased with increasing age, longer duration of atrial fibrillation (>3 days), mitral valve stenosis, and enlarged heart chamber size. With those factors, there is about 50-60% chance that your atrial fibrillation may continue to be recurrent and you may find yourself having to go through this procedure repeatedly. This may still be preferable to staying in atrial fibrillation.
Conversion to sinus rhythm may present a special risk for stroke in patients with atrial fibrillation. In preparation for the DC cardioversion, you may need to have the transesophageal echocardiography (TEE). As described earlier, this technique involves imaging the heart using a special probe placed in the esophagus while you are under light anesthesia. Your doctor may have you take warfarin for 3 to 4 weeks prior to the cardioversion. This therapy will allow blood clots already formed in the atria to be removed by the body's natural clot dissolving factors, thus minimizing the risk of embolic stroke during or shortly after cardioversion. Warfarin therapy is usually continued for at least 4 weeks after the procedure as the atrial contraction capability slowly recovers.
You may try many medications only to find that the symptoms of your atrial fibrillation remain intolerable even if the heart rate is under control. You may find that the side effects caused by the medications make you feel so uncomfortable that it becomes difficult to comply with your medical regimen on a long-term basis. You may encounter such serious side effect as organ toxicity, ventricular arrhythmia, or heart failure, forcing your doctor to discontinue them. After taking the same medications for a long time, you may reach a point at which they don't work as well as they did when you first began taking them.
The most common treatment now available is AV node ablation. In this procedure, which is a part of an electrophysiology study, a small wire is introduced into the large veins and guided to the heart using fluoroscopy (X-ray camera). The normal electrical conduction system is interrupted by a small burn produced by the use of RF catheter (radiofrequency catheter) on the AV node. This will block the many electrical impulses in the atria from reaching the ventricles and effectively stops them from beating rapidly and irregularly. In almost all cases, RF catheter ablation causes a complete block of the AV node. A permanent pacemaker is then implanted to assist the heart to maintain an adequate heart rate. There are two basic kinds of pacemakers, the traditional single chamber (ventricular) pacemaker and the sequential dual chamber (atrio-ventricular, or "DDD") pacemaker.
While AV node ablation can significantly reduce the symptoms associated with the arrhythmia, it must be stressed that this treatment does not cure atrial fibrillation. It is only that the ventricles are prevented from making the heart beat too rapidly and erratically. Many of the medications for atrial fibrillation can usually be stopped at this point, but the final decision is up to your doctor. The blood thinners will likely need to be continued because either your atria continue to fibrillate, or there is a high probability of the arrhythmia recurring. In an even newer form of treatment, a pacemaker may be implanted without ablating the AV node in an attempt to keep you in sinus rhythm, sometimes by pacing from more than one location in the atrium. Perhaps the newest and most innovative type of device that can be implanted for patients with atrial fibrillation is a device called an implanted atrial defibrillator or arrhythmia management device (AMD). These are devices that can sense when the heart goes into atrial fibrillation and give a low voltage shock or jolt of electricity via small permanent wires implanted in the heart to jump-start the normal rhythm again. New features are being added to these devices, such as the pacemaker capability to prevent atrial fibrillation from occurring. Patients who will benefit are those with infrequent but symptomatic long lasting episodes of atrial fibrillation despite maximal drug therapy. It should be noted that because of the troubling nature of atrial fibrillation, many patients require more than one mode of treatment at the same time, something called "hybrid therapy". For example, patients with the so-called "tachy-brady syndrome" may need a pacemaker for the slow heart rhythm and drug treatment for the atrial fibrillation. Another type of hybrid therapy involves making a combination of linear atrial lesions with a radiofrequency catheter with implanting an atrial defibrillator. Finally, in some patients, atrial firbrillation can be cured with RF catheter ablation. This is discussed in the next section "Cure". |
[ |
|
| EP Home | Overview | Faculty & Staff | Research | For Healthcare Consumers | | For UCSF Electrophysiology Patients | For Referring Physicians | To Reach Us | | Return to The Division of Cardiology at UCSF Website | |
| Last updated by Web Administrator |